Table 2 Participant baseline characteristics
Standard clinic (n = 18) | Text message-enhanced clinic (n = 18) | Overall (n = 36) | |
|---|---|---|---|
Age (years) | 61.3 ± 9.1 | 68.3 ± 9.1 | 64.8 ± 9.6 |
Body mass index (kg/m2) | 26.1 ± 4.2 | 26.5 ± 3.9 | 26.3 ± 4.0 |
Gender (male) | 11 (61%) | 12 (67%) | 23 (64%) |
Primary cancer | |||
Colorectal | 12 (67%) | 13 (72%) | 25 (69%) |
Prostate | 5 (28%) | 5 (28%) | 10 (28%) |
Breast | 1 (6%) | 0 (0%) | 1 (3%) |
Number of medications | |||
None | 4 (22%) | 4 (22%) | 8 (22%) |
1 | 3 (17%) | 2 (11%) | 5 (14%) |
≥ 2 | 11 (61%) | 12 (67%) | 23 (64%) |
Post-diagnosis (months) | 54.5 (38.0, 72.0) | 60.0 (47.0, 71.0) | 57.5 (43.5, 71.5) |
Post treatment (months) | 38.5 (25.0, 66.0) | 51.0 (10.0, 61.0) | 46.0 (24.5, 61.0) |
Activity (activPAL micro)a | |||
Wear time (h) | 15.7 ± 0.7 | 15.9 ± 0.9 | 15.8 ± 0.8 |
Sitting (h/16 h) | 9.4 ± 2.1 | 9.5 ± 1.8 | 9.4 ± 1.9 |
Prolonged sitting (h/16 h) | 4.6 ± 2.2 | 4.7 ± 1.8 | 4.7 ± 2.0 |
Standing (h/16 h) | 4.3 ± 1.5 | 4.3 ± 1.3 | 4.3 ± 1.4 |
Stepping (h/16 h) | 2.4 ± 0.8 | 2.1 ± 0.7 | 2.3 ± 0.8 |
Light stepping (min/16 h) | 95.3 ± 26.3 | 98.2 ± 22.8 | 96.7 ± 24.3 |
MVPA (min/16 h) | 43.7 ± 28.8 | 31.1 ± 19.4 | 37.4 ± 25 |